CN Patent

CN116390712A — 治疗偏头痛

Assigned to Allergan Pharmaceuticals Holdings Ireland ULC · Expires 2023-07-04 · 3y expired

What this patent protects

本公开提供了用于通过施用阿托吉泮或其药学上可接受的盐来治疗偏头痛的方法。

USPTO Abstract

本公开提供了用于通过施用阿托吉泮或其药学上可接受的盐来治疗偏头痛的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116390712A
Jurisdiction
CN
Classification
—
Expires
2023-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Pharmaceuticals Holdings Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.